다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

RNXT

RenovoRx (RNXT)

RenovoRx Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:RNXT

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/01/22	23:00	PR Newswire (Canada)	Oncology's Best Minds Set to Meet at Upcoming 2025 ASCO Gastrointestinal Cancers Symposium	NASDAQ:RNXT	RenovoRx Inc
2025/01/22	23:00	PR Newswire (US)	Oncology's Best Minds Set to Meet at Upcoming 2025 ASCO Gastrointestinal Cancers Symposium	NASDAQ:RNXT	RenovoRx Inc
2025/01/22	23:00	PR Newswire (US)	Oncology's Best Minds Set to Meet at Upcoming 2025 ASCO Gastrointestinal Cancers Symposium	NASDAQ:RNXT	RenovoRx Inc
2025/01/08	22:00	Business Wire	RenovoRx Announces Acceptance of Abstract for Presentation at ASCO Gastrointestinal Cancers Symposium 2025	NASDAQ:RNXT	RenovoRx Inc
2024/12/30	22:00	Business Wire	RenovoRx Continues to Grow Intellectual Property Portfolio for its Novel Drug-Delivery Therapy Platform	NASDAQ:RNXT	RenovoRx Inc
2024/12/11	22:00	GlobeNewswire Inc.	RenovoRx Initiates Patient Enrollment at SCRI Oncology Partners for Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial in Locally Advanced Pancreatic Cancer	NASDAQ:RNXT	RenovoRx Inc
2024/12/10	22:00	GlobeNewswire Inc.	RenovoRx CEO to Host Investor Fireside Chat on Tuesday, December 17th at 4:30 p.m. ET	NASDAQ:RNXT	RenovoRx Inc
2024/12/05	22:00	GlobeNewswire Inc.	RenovoRx Receives First Purchase Orders for its FDA-Cleared RenovoCath® Delivery System	NASDAQ:RNXT	RenovoRx Inc
2024/11/20	22:45	GlobeNewswire Inc.	Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx’s Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial	NASDAQ:RNXT	RenovoRx Inc
2024/11/14	22:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RNXT	RenovoRx Inc
2024/11/14	22:00	GlobeNewswire Inc.	RenovoRx Reports Third Quarter 2024 Financial Results and Operational Highlights	NASDAQ:RNXT	RenovoRx Inc
2024/11/14	06:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RNXT	RenovoRx Inc
2024/10/03	05:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNXT	RenovoRx Inc
2024/10/03	05:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNXT	RenovoRx Inc
2024/09/26	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RNXT	RenovoRx Inc
2024/09/25	21:30	GlobeNewswire Inc.	RenovoRx Increases Production of FDA-Cleared RenovoCath® Delivery System in Response to Strong Demand from Oncology and Interventional Radiology Physicians	NASDAQ:RNXT	RenovoRx Inc
2024/09/19	21:30	GlobeNewswire Inc.	RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology Highlighting TAMP™ for Targeted Treatment of Locally Advanced Pancreatic Cancer	NASDAQ:RNXT	RenovoRx Inc
2024/08/27	21:30	GlobeNewswire Inc.	RenovoRx CEO Shaun Bagai to Present at H.C. Wainwright’s 26th Annual Global Investment Conference on September 9, 2024 in New York	NASDAQ:RNXT	RenovoRx Inc
2024/08/17	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RNXT	RenovoRx Inc
2024/08/14	21:30	GlobeNewswire Inc.	RenovoRx Announces First Patient Enrolled at University of Nebraska Medical Center for the Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial	NASDAQ:RNXT	RenovoRx Inc
2024/08/14	06:03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RNXT	RenovoRx Inc
2024/07/31	21:30	GlobeNewswire Inc.	RenovoRx Announces Publication of Positive Early-Stage Clinical Data in International Peer-Reviewed Journal, The Oncologist®	NASDAQ:RNXT	RenovoRx Inc
2024/07/08	21:30	GlobeNewswire Inc.	RenovoRx Announces Acceptance for Publication in the International Peer-Reviewed Journal, The Oncologist®	NASDAQ:RNXT	RenovoRx Inc
2024/06/26	21:30	GlobeNewswire Inc.	University of Nebraska Medical Center Launches Patient Enrollment for RenovoRx’s Pivotal Phase III TIGeR-PaC Clinical Trial	NASDAQ:RNXT	RenovoRx Inc
2024/06/10	21:30	GlobeNewswire Inc.	RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships	NASDAQ:RNXT	RenovoRx Inc
2024/06/08	05:41	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RNXT	RenovoRx Inc
2024/05/30	21:30	Business Wire	RenovoRx CEO Issues Update Letter to Shareholders	NASDAQ:RNXT	RenovoRx Inc
2024/05/21	22:00	Business Wire	Publication of Results of Pre-Clinical Studies Support Efficacy and Drug Delivery Mechanism Potential of RenovoRx’s TAMP™ Therapy Platform to Improve Targeted Cancer Drug Treatment Delivery	NASDAQ:RNXT	RenovoRx Inc
2024/05/14	22:00	Business Wire	RenovoRx to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase on May 21, 2024	NASDAQ:RNXT	RenovoRx Inc
2024/05/13	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:RNXT	RenovoRx Inc

검색 관련기사 보기:NASDAQ:RNXT

1 2 3 4 5 6 7 다음 >>

Health Care Select Sector

Bank of America

US Dollar vs Yen

Verizon Communications

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관